0001562180-19-003640.txt : 20190625
0001562180-19-003640.hdr.sgml : 20190625
20190625171817
ACCESSION NUMBER: 0001562180-19-003640
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190621
FILED AS OF DATE: 20190625
DATE AS OF CHANGE: 20190625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kanes Stephen
CENTRAL INDEX KEY: 0001612859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 19919377
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-06-21
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001612859
Kanes Stephen
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
Chief Medical Officer
Stock Option (Right to Buy)
47.70
2019-06-21
4
A
false
6600.00
0.00
A
2027-02-06
Common Stock
6600.00
13200.00
D
On February 6, 2017, the reporting person was granted an option to purchase 20,000 shares of common stock. The option vests upon the achievement of certain milestones, one of which was met on June 21, 2019, resulting in the vesting of the option as to 6,600 shares.
/s/ Anne Marie Cook as Attorney-in-Fact for Stephen Kanes
2019-06-25